Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Asia Pacific Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

Published Date : 31-May-2023

Pages: 94

Formats: PDF

The Asia Pacific Oral Antiviral Market would witness market growth of 3.2% CAGR during the forecast period (2023-2029).

The market is expanding due to several causes, including an expanding patient population, an increase in viral disease cases, and rising disease awareness. In addition, the market is expanding due to growing awareness of the need for early disease detection, rising healthcare expenditures in emerging nations, rising government and industry investment, and other factors. The market expansion is anticipated to be fueled by regulatory approvals for special drug designation for treatment and a robust R&D pipeline.

Many people with an uncomplicated case of influenza take over-the-counter medications, rest, and drink lots of water to ease their symptoms. Antiviral medications, available by prescription, can shorten recovery from symptoms. Some can also be used in specific circumstances to lessen the likelihood that those exposed to the influenza virus would become ill. The best results from antiviral medications may be seen in people who begin treatment within 48 hours of the onset of symptoms. Therefore, prompt medical examination is crucial for the early treatment of influenza.

The economic growth of this region is influenced by the development of the healthcare infrastructure, the expansion of government initiatives to boost the uptake of treatments and the regional expansion of significant corporations in Asian nations. The rising prevalence of herpes in developing countries such as China and India is also expected to contribute to development. Since there are numerous regional companies, the market is dispersed, which increases the rate at which oral antiviral medications are used for treating herpes. Asia-Pacific offers lucrative potential for key players operating in the market due to improvements in sector infrastructure, a rise in spending power, and the well-established presence of market players in the region.

The China market dominated the Asia Pacific Oral Antiviral Market by Country in 2022 thereby, achieving a market value of $2,989.9 million by 2029. The Japan market is exhibiting a CAGR of 2.6% during (2023 - 2029). Additionally, The India market would experience a CAGR of 3.8% during (2023 - 2029).

Based on Indication, the market is segmented into Human Immunodeficiency Virus (HIV), Hepatitis, Influenza and Others. Based on Drug Class, the market is segmented into Reverse Transcriptase Inhibitors, Protease Inhibitors and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Oral Antiviral Market is Projected to reach USD 41.2 Billion by 2029, at a CAGR of 2.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol Myers Squibb Company, Gilead Sciences, Inc., Viatris, Inc. (Mylan N.V.), AbbVie, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceutical Industries Ltd., and Amneal Pharmaceuticals, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Indication

  • Human Immunodeficiency Virus (HIV)
  • Hepatitis
  • Influenza
  • Others

By Drug Class

  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • Others

By Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company
  • Gilead Sciences, Inc.
  • Viatris, Inc. (Mylan N.V.)
  • AbbVie, Inc.
  • GlaxoSmithKline PLC (GSK)
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Oral Antiviral Market, by Indication
1.4.2 Asia Pacific Oral Antiviral Market, by Drug Class
1.4.3 Asia Pacific Oral Antiviral Market, by Distribution Channel
1.4.4 Asia Pacific Oral Antiviral Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Oral Antiviral Market by Indication
3.1 Asia Pacific Human Immunodeficiency Virus (HIV) Market by Country
3.2 Asia Pacific Hepatitis Market by Country
3.3 Asia Pacific Influenza Market by Country
3.4 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Oral Antiviral Market by Drug Class
4.1 Asia Pacific Reverse Transcriptase Inhibitors Market by Country
4.2 Asia Pacific Protease Inhibitors Market by Country
4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Oral Antiviral Market by Distribution Channel
5.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
5.2 Asia Pacific Hospital Pharmacies Market by Country
5.3 Asia Pacific Online Providers Market by Country

Chapter 6. Asia Pacific Oral Antiviral Market by Country
6.1 China Oral Antiviral Market
6.1.1 China Oral Antiviral Market by Indication
6.1.2 China Oral Antiviral Market by Drug Class
6.1.3 China Oral Antiviral Market by Distribution Channel
6.2 Japan Oral Antiviral Market
6.2.1 Japan Oral Antiviral Market by Indication
6.2.2 Japan Oral Antiviral Market by Drug Class
6.2.3 Japan Oral Antiviral Market by Distribution Channel
6.3 India Oral Antiviral Market
6.3.1 India Oral Antiviral Market by Indication
6.3.2 India Oral Antiviral Market by Drug Class
6.3.3 India Oral Antiviral Market by Distribution Channel
6.4 South Korea Oral Antiviral Market
6.4.1 South Korea Oral Antiviral Market by Indication
6.4.2 South Korea Oral Antiviral Market by Drug Class
6.4.3 South Korea Oral Antiviral Market by Distribution Channel
6.5 Singapore Oral Antiviral Market
6.5.1 Singapore Oral Antiviral Market by Indication
6.5.2 Singapore Oral Antiviral Market by Drug Class
6.5.3 Singapore Oral Antiviral Market by Distribution Channel
6.6 Malaysia Oral Antiviral Market
6.6.1 Malaysia Oral Antiviral Market by Indication
6.6.2 Malaysia Oral Antiviral Market by Drug Class
6.6.3 Malaysia Oral Antiviral Market by Distribution Channel
6.7 Rest of Asia Pacific Oral Antiviral Market
6.7.1 Rest of Asia Pacific Oral Antiviral Market by Indication
6.7.2 Rest of Asia Pacific Oral Antiviral Market by Drug Class
6.7.3 Rest of Asia Pacific Oral Antiviral Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Merck & Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Bristol Myers Squibb Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Gilead Sciences, Inc.
7.5.1 Company overview
7.5.2 Financial Analysis
7.5.3 Research & Development Expenses
7.6 Viatris, Inc. (Mylan N.V.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expense
7.7 AbbVie, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 GlaxoSmithKline PLC (GSK)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Amneal Pharmaceuticals, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental Analysis
7.10.4 Research & Development Expenses
TABLE 1 Asia Pacific Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 3 Asia Pacific Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 5 Asia Pacific Human Immunodeficiency Virus (HIV) Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Human Immunodeficiency Virus (HIV) Market by Country, 2023 - 2029, USD Million
TABLE 7 Asia Pacific Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Hepatitis Market by Country, 2023 - 2029, USD Million
TABLE 9 Asia Pacific Influenza Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Influenza Market by Country, 2023 - 2029, USD Million
TABLE 11 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 13 Asia Pacific Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 15 Asia Pacific Reverse Transcriptase Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Reverse Transcriptase Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 17 Asia Pacific Protease Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Protease Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 19 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 21 Asia Pacific Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 27 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 29 Asia Pacific Oral Antiviral Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Oral Antiviral Market by Country, 2023 - 2029, USD Million
TABLE 31 China Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 32 China Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 33 China Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 34 China Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 35 China Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 36 China Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 37 China Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 38 China Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 39 Japan Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 40 Japan Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 41 Japan Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 42 Japan Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 43 Japan Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 44 Japan Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 45 Japan Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Japan Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 47 India Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 48 India Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 49 India Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 50 India Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 51 India Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 52 India Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 53 India Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 India Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 55 South Korea Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 56 South Korea Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 57 South Korea Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 58 South Korea Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 59 South Korea Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 60 South Korea Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 61 South Korea Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 South Korea Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 63 Singapore Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 64 Singapore Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 65 Singapore Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 66 Singapore Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 67 Singapore Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 68 Singapore Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 69 Singapore Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 Singapore Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 Malaysia Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 72 Malaysia Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 73 Malaysia Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 74 Malaysia Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 75 Malaysia Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 76 Malaysia Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 77 Malaysia Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 78 Malaysia Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 79 Rest of Asia Pacific Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 81 Rest of Asia Pacific Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 83 Rest of Asia Pacific Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 84 Rest of Asia Pacific Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 85 Rest of Asia Pacific Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Rest of Asia Pacific Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 87 Key information –Johnson & Johnson
TABLE 88 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 89 KEY INFORMATION - Merck & Co., Inc.
TABLE 90 Key Information – Bristol Myers Squibb Company
TABLE 91 Key Information – Gilead Sciences, Inc.
TABLE 92 key information – Viatris, Inc.
TABLE 93 Key information – AbbVie, Inc.
TABLE 94 Key Information – GlaxoSmithKline PLC
TABLE 95 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 96 Key Information – Amneal Pharmaceuticals, INc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Oral Antiviral Market Share by Indication, 2022
FIG 3 Asia Pacific Oral Antiviral Market Share by Indication, 2029
FIG 4 Asia Pacific Oral Antiviral Market by Indication, 2019 - 2029, USD Million
FIG 5 Asia Pacific Oral Antiviral Market Share by Drug Class, 2022
FIG 6 Asia Pacific Oral Antiviral Market Share by Drug Class, 2029
FIG 7 Asia Pacific Oral Antiviral Market by Drug Class, 2019 - 2029, USD Million
FIG 8 Asia Pacific Oral Antiviral Market Share by Distribution Channel, 2022
FIG 9 Asia Pacific Oral Antiviral Market Share by Distribution Channel, 2029
FIG 10 Asia Pacific Oral Antiviral Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 Asia Pacific Oral Antiviral Market Share by Country, 2022
FIG 12 Asia Pacific Oral Antiviral Market Share by Country, 2029
FIG 13 Asia Pacific Oral Antiviral Market by Country, 2019 - 2029, USD Million
FIG 14 SWOT analysis: Johnson & Johnson

Purchase Full Report of
Asia Pacific Oral Antiviral Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL